​​​​​​​​​​​​​ <back

Online events

E-Discussions and Webinars between staff from the Cooperation Offices, the headquarters in Berne as well as SDC partners and implementing NGOs.

PSE in Health Cooperation Webinar Series

In 2021, the SDC Health Network invites you to attend a series of webinars every second Wednesday of the month, between March and September. We will explore the different forms of private sector engagement in health, and discuss challenges and opportunities in public-private partnerships.


March 10: Private Sector Engagement (PSE) in health cooperation: an introduction. 

April 14: Strengthening pro-poor markets for health and enhancing the role of local businesses

May 12Teaming up to improve access to health technologies - Part I: Strenghtening collaboration towards needs-based R&D for lower-income settings.

June 16Teaming up to improve access to health technologies - Part II: Ensuring quality​ of affordable products in lower-income settings

July 23: Teaming-up with the private sector in emergency settings​

September 08: Private foundations and philanthropies in health

October 13: Wrap-up session: what does it mean for my own context? (reserved for SDC staff)

>Register for individual webinars.

>More information, session materials and discussion board

*Event dates and programme might change according to external experts' availabilities

SDC Learning Event: Antimicrobial resistance - a silent pandemic

April 30, 2021 - The SDC Health, A+FS and Water networks co-organised a learning event on antimicrobial resistance (AMR) to raise awareness on a growing cross-sectorial challenge. SDC colleagues from HQ and from the field presented projects and intiatives across different areas, highlighting current efforts and new opprotunities to adress this urgent issue. 

For more details, see the event summary and the following additional resources:

Presentations and further information on SDC programmes:
- AMR introduction, Corinne Corradi, GPH
- One Health projects in the Horn of Africa, Lensse Gobu Bonga, Swiss Embassy Ethiopia:
   Jigjiga University One Health Initiative, JOHI - One-world article and Rural21 article
   One Health for Humans, Environment, Animals and Livelihoods project, HEAL - overview
- Collaboration with pharmaceutical manufacturers in India, RAMP, Sakshi Dasgupta, Swiss Embassy India and RAMP one-pager
- Swiss National Strategy (StAR), Corinne Corradi, GPH

Additional resources on AMR:
- Monitoring global progress on antimicrobial resistance: Tripartite AMR country self-assessment survey (TRACSS) 2021-2020, Global Analysis Report, FAO, OIE, WHO (PDF)
- 2020 Antimicrobial Benchmark, Access to Medicine Foundation report
- Pulling Together to Beat Superbugs: Knowledge and Implementation Gaps in Adressing Antmicrobial Resistance (2019), World Bank Group (PDF)
- WHO Antimicrobial resistance webpage (general information)

(image extracted from the video Antimicrobial Resistance - African Region FAO)

Partnership in the Fight against NTDs in the Next Decade: What Kind of Innovation?

March​ 1, 2021 – The Swiss Alliance against Neglected Tropical Diseases (SANTD), in collaboration with SDC, held a webinar on the transition from a disease-specific approach to cross-cutting collaborations in fighting against Neglected Tropical Diseases (NTDs), highlighting the importance of health determinants and innovation. Partners from different sectors shared their experiences, followed by a panel discussion on approaches and innovations for more intersectoral interventions in the fight against NTDs.

Guest speakers: Dr. Mwele Male​cela (WHO); Anthony Mann (Novartis), Dr. Olaf Valverde (DNDi), Dr. Joseph Ndung'u (FIND), ​Dr Jutta Reinhard-Rupp (Merck Global Health Institute) and Dr. Stefanie Knopp (Swiss TPH).​

Panelists: Dr Alexander Schulze (SDC), Dr Lutz Hegemann (Novartis), Dr Mwele Malecela (WHO) and Dr Peter Steinmann​ (Swiss TPH)

For further details: presentations and event recording​

​The Swissmedic Marketing Authorisation for Global Health Products (MAGHP) Procedure – Progress update and lessons learned

February 23, 2021 – The SDC held a virtual event in collaboration with Swissmedic, the Swiss Agency for Therapeutic Products, and an expert panel from national medical authorities (Tanzania, Ghana) and the World Health Organisation (WHO).​

The main objectives were to present the Swissmedic Marketing Authorisation for Global Health Products (MAGHP) and its added value in terms of capacity strengthening and access to medical products, particularly in low-income countries. Guest speakers presented lessons learned from first experiences, in particular in Tanzania and Ghana, and discussed the main benefits and challenges of MAGHP's procedure, as well as possible ways to move forward.​

Here is the event recording.

Presentations and speakers:

1. Progress update on the MAGHP Procedure, Jörg Schläpfer & Lodovico Paganini
2. Tanzania Medicines & Medical Devices Authority​ (TMDA) experience in the MAGHP procedure, Felchism Apolnary

Moderator: Dr. Alexandre Schulze, co-head of Global Programme Health, SDC

Toward an equitable access to SARS-CoV-2 vaccines for all: what is GAVI COVAX AMC offering to lower income countries?

February 17, 2021 The SDC Health Network organized a webinar with experts from GAVI and the Asian Development Bank.

The main objectives were to get to know the different types of COVID-19 vaccines, as well as their advantages and disadvantages in different contexts, and to understand the financial and procurement mechanisms proposed by GAVI and multilateral development banks, such as the World Bank and the Asian Development Bank (ADB).


80 participants from 60 countries attended this event. Here are the presentations shared:


Alternative text

Testing for SARS-CoV-2: Ensuring access to COVID-19 rapid diagnostics tests for LMICs​

December 9, 2020 ​ The SDC Health Network organized a webinar with experts from FIND and the Global Fund. 
The main objectives were to understand the value of early and mass testing to combat the COVID-19 pandemic; get to know the different types of COVID-19 tests and identify the most appropriate to your context; be informed about global efforts on R&D, procurement and distribution of COVID-19 tests; and reflect on SDC intervention opportunities at the country level. 
57 participants fom 35 countries attended this event. Here are the presentations shared. 

Previous online events


E-Discussion "Health Systems Strenghtning" (HSS) >>
E-Discussion "Quality of Care" >>


E-Discussion "WASH" >>

E-Discussion "Health System Strengthening" (HSS)

The E-discussion on HSS was conducted from 23rd November to 4th December 2015.
Over-arching topics discussed:

  • Assessing strengths and gaps in HSS to identify where support is needed and by whom
  • Lessons learned from different interventions and outcomes (e.g. International Health Partnership methodology Mozambique).
  • Measurability of HSS
  • Actors: Who does what and how, and with what results? What can SDC expect from different players?
  • Stewardship: As only a few governments have the capacity or the will to lead HSS, who should lead and on which levels? What do we mean by stewardship?
  • Influencing policy dialogue: Alignment and coordination.

You will find more information as well as access to the contributions in the CUG.

E-Discussion "Quality of Care"

The E-discussion on Quality of Care took place between 2nd and 14th of February 2015.
By the end of this E-Discussion participants were supposed to have:

  • Established a basic common understanding of Quality of Care
  • Gained a solid overview of different approaches to improve Quality of Care
  • Shared experience and identified technical resources
  • Connected people (across countries and institutions)
  • Discussed relevant guidance documents and concepts
  • Assessed the needs for further support and advice.

Summary of the E-Discussion "Quality of Care"

You will find more information in the CUG.

E-Discussion "WASH"

WASH (water supply, sanitation and hygiene) in health facilities is a relevant issue for many of SDC’s water and health programmes. Specific guidance on how to consider the specificities of WASH in health facilities are helpful for programme staff when planning and implementing programmes. 

The objectives of the discussion were:

  • To establish a basic understanding of the needs regarding water, sanitation and hygiene (WASH) and recommended practices in Health Facilities
  • To facilitate access of the field staff involved in planning and implementation of programs for WASH in Health Facilities to experiences of other programs, relevant guidance documents and expert contacts
  • To assess needs for further support and advice of field staff involved in planning and implementation of programmes for WASH in Health Facilities in low resource contexts

Some learning results:

  1. Health facilities and their employees have a high reputation in communities and their voice would be heard. But with great power comes great responsibility. It is therefore important to educate/train staff in order to disseminate knowledge and demonstrate model behaviour regarding hygiene. Health facilities might have a high potential to trigger behaviour change not only in patients but also in visitors and staff as well as to raise awareness about different needs of various social groups (gender specificities, aged, disabled etc.). However, the transmission from the clinical, somehow artificial environment in the health center, into everyday life at home might not be as easy as it seems at first sight. (p. 4-5, summary).

  2. The conclusion of the second discussion phase on WASH in Health Facilities might be that we do not have to reinvent the wheel. Tools for the assessment of the current WASH situation exist and adequate technologies have been introduced in health centers before. There is, however, a great potential for the exchange of information within and between the different sections and institutions of the RésEAU and the Health Network and a joint approach to develop general guidelines has been proposed. (p. 6, summary)

Summary of E-Discussion WASH

You will find more information in the CUG.